These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5578330)

  • 1. Fibrinogen degradation products.
    Sack ES; Buraschi J
    N Engl J Med; 1971 Jun; 284(25):1441. PubMed ID: 5578330
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of fibrinogen degradation products.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis.
    van Outryve M; Baele G; de Weerdt GA; Barbier F
    Scand J Haematol; 1973; 11(2):148-52. PubMed ID: 4773962
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases.
    Thomas DP; Niewiarowski S; Myers AR; Bloch KJ; Colman RW
    N Engl J Med; 1970 Sep; 283(13):663-8. PubMed ID: 4247823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies].
    Thuot C; Perron L
    Union Med Can; 1973 Jan; 102(1):66-9. PubMed ID: 4706340
    [No Abstract]   [Full Text] [Related]  

  • 8. Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
    Neri Serneri GG; Gensini GF; Abbate R; Favilla S
    Thromb Haemost; 1980 Feb; 42(5):1561-73. PubMed ID: 6768154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
    Soria J; Soria C; Vairel E; Prost RJ; Warneson G
    Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical significance of the plasminogen level.
    Lackner H; Javid JP
    Am J Clin Pathol; 1973 Aug; 60(2):175-81. PubMed ID: 4720396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of serum fibrinogen degradation products using Merskey's technic, Apropos of 169 cases].
    Kolodié L; Seigneurin D; Micouin C; Hollard D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():66-71. PubMed ID: 4219980
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of fibrinogen degradation product in severe liver disorders by immunoblotting.
    Tanaka M; Ohkita T
    Tohoku J Exp Med; 1987 Nov; 153(3):179-87. PubMed ID: 3433274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet and fibrinogen consumption in man.
    Harker LA; Slichter SJ
    N Engl J Med; 1972 Nov; 287(20):999-1005. PubMed ID: 4675535
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated fibrin-related markers in patients with malignant diseases suspected of having thrombotic disorders.
    Nomura H; Wada H; Mizuno T; Yamashita Y; Saito K; Kitano S; Katayama N; Yamada N; Sugiyama T; Sudo A; Usui M; Isaji S; Nobori T
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):266-72. PubMed ID: 19648145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intravascular and extravascular coagulation on serum fibrin degradation products in rats.
    Vanstone JC; Khoury NY
    Thromb Diath Haemorrh; 1971; 25(1):142-6. PubMed ID: 4996073
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmunoassays of human fibrinopeptides A and B.
    Budzyński AZ; Marder VJ
    Pol Arch Med Wewn; 1978 Jan; 59(1):43-8. PubMed ID: 349523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.